(42) have demonstrated that LMNB2 was responsible for the malignant phenotype of non-small cell lung carcinoma (NSCLC) through upregulating demethylation of H3K9, the mechanism of SNHG1 in HCC progression still needs further investigation. Here, LMNB2 is linked to non-small cell lung carcinoma.